Skip to main content
. 2020 Jan 14;11(3):594–602. doi: 10.1111/1759-7714.13302

Table 2.

Adverse events of every dosage (n = 28)

Dose 150 mg (n = 2) 200 mg (n = 5) 250 mg (n = 4) 300 mg (n = 17) Total N (%)
Rash 0 0 2 3 5 (17.9%)
Pruritus 1 0 0 2 3 (10.7%)
Skin chapped 0 1 0 1 2 (7.1%)
Liver function abnormal 2 2 3 3 10 (35.7%)
Nausea/vomiting 1 0 1 1 3 (10.7%)
Abdominal distention 0 1 0 2 3 (10.7%)
Loss of appetite 0 1 0 0 1 (3.6%)
Constipation 0 0 0 1 1 (3.6%)
Diarrhea 0 1 0 9 10 (35.7%)
Neutropenia 0 1 1 2 4 (14.3%)
Thrombocytopenia 0 1 1 0 2 (7.1%)
Interstitial lung disease 0 0 0 1 1 (3.6%)

One of the adverse effect was grade 3 in each group, respectively.